Bed, Bath and Beyond 2013 Annual Report Download - page 36

Download and view the complete annual report

Please find page 36 of the 2013 Bed, Bath and Beyond annual report below. You can navigate through the pages in the report by either clicking on the pages listed below, or by using the keyword search tool below to find specific information within the annual report.

Page out of 80

  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • 11
  • 12
  • 13
  • 14
  • 15
  • 16
  • 17
  • 18
  • 19
  • 20
  • 21
  • 22
  • 23
  • 24
  • 25
  • 26
  • 27
  • 28
  • 29
  • 30
  • 31
  • 32
  • 33
  • 34
  • 35
  • 36
  • 37
  • 38
  • 39
  • 40
  • 41
  • 42
  • 43
  • 44
  • 45
  • 46
  • 47
  • 48
  • 49
  • 50
  • 51
  • 52
  • 53
  • 54
  • 55
  • 56
  • 57
  • 58
  • 59
  • 60
  • 61
  • 62
  • 63
  • 64
  • 65
  • 66
  • 67
  • 68
  • 69
  • 70
  • 71
  • 72
  • 73
  • 74
  • 75
  • 76
  • 77
  • 78
  • 79
  • 80

The weighted average fair value for the stock options granted in fiscal 2013, 2012 and 2011 was $22.28, $22.95 and $19.65,
respectively. The weighted average remaining contractual term and the aggregate intrinsic value for options outstanding as of
March 1, 2014 was 3.9 years and $89.7 million, respectively. The weighted average remaining contractual term and the aggregate
intrinsic value for options exercisable as of March 1, 2014 was 2.7 years and $69.1 million, respectively. The total intrinsic value for
stock options exercised during fiscal 2013, 2012 and 2011 was $44.6 million, $38.8 million and $101.5 million, respectively.
Net cash proceeds from the exercise of stock options for fiscal 2013 were $54.8 million and the net associated income tax
benefit was $20.1 million.
Restricted Stock
Restricted stock awards are issued and measured at fair market value on the date of grant and generally become vested in five
equal annual installments beginning one to three years from the date of grant, subject, in general, to the recipient remaining
in the Company’s employ or service on specified vesting dates. Vesting of restricted stock awarded to certain of the Company’s
executives is dependent on the Company’s achievement of a performance-based test for the fiscal year of grant and, assuming
achievement of the performance-based test, time vesting, subject, in general, to the executive remaining in the Company’s
employ on specified vesting dates. The Company recognizes compensation expense related to these awards based on the
assumption that the performance-based test will be achieved. Vesting of restricted stock awarded to the Company’s other
employees is based solely on time vesting.
Changes in the Company’s restricted stock for the fiscal year ended March 1, 2014 were as follows:
(Shares in thousands)
Number of
Restricted Shares
Weighted Average
Grant-Date
Fair Value
Unvested restricted stock, beginning of period 4,063 $45.98
Granted 1,016 69.82
Vested (988) 38.76
Forfeited (148) 53.34
Unvested restricted stock, end of period 3,943 $53.66
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(continued)
BED BATH & BEYOND 2013 ANNUAL REPORT
34